Review Article

A pragmatic approach to the diagnosis of inborn errors of metabolism in developing countries

John I. Anetor, Bose E. Orimadegun, Gloria O. Anetor
African Journal of Laboratory Medicine | Vol 12, No 1 | a1946 | DOI: https://doi.org/10.4102/ajlm.v12i1.1946 | © 2023 John I. Anetor, Bose E. Orimadegun, Gloria O. Anetor | This work is licensed under CC Attribution 4.0
Submitted: 30 April 2022 | Published: 30 May 2023

About the author(s)

John I. Anetor, Department of Chemical Pathology, Faculty of Basic Medical Sciences, University of Ibadan, Ibadan, Nigeria
Bose E. Orimadegun, Department of Chemical Pathology, Faculty of Basic Medical Sciences, University of Ibadan, Ibadan, Nigeria
Gloria O. Anetor, Department of Public Health Science, Faculty of Health Sciences, National Open University of Nigeria, Abuja, Nigeria

Abstract

Inborn errors of metabolism (IEM) are a group of genetically derived diseases that are individually rare but collectively common and can be very severe. While high-income countries usually employ modern scientific technologies like tandem mass spectrometry for IEM investigation, these disorders are, in contrast, only rarely screened for in developing countries due to misconceptions that the required facilities are beyond the reach of these countries. This paper attempts to educate scientists and clinicians in developing countries on low-technology IEM screening methods that only require moderate facilities. Although a definitive diagnosis of IEM may require specialised laboratory investigations and attendant interpretation, in most cases, the basic facilities available in the average clinical chemistry laboratory in developing countries can allow the early detection of IEM. This early detection would facilitate critical early decision making, thus leading to better management, optimised treatment, and reduced morbidity and or mortality of IEM in these resource-limited countries. With this approach, a few referral centres for confirmatory investigation, comparable to those existing in developed countries, could be established. This can be integrated into creative health education for healthcare professionals and families who have individuals with IEM.

What this study adds: IEMs are important enough that every country, developed or developing, should have screening plans and basic laboratory facilities that are adequate for initial IEM diagnosis. No country should therefore give up on testing for IEMs on the excuse of a paucity of advanced facilities.


Keywords

basic laboratory investigations; developing countries; inborn errors of metabolism; health education; optimisation of treatment

Metrics

Total abstract views: 3656
Total article views: 8865

 

Crossref Citations

1. The status of newborn screening in Africa: Situation analysis, future plans and call to action
Tumelo Satekge, Adekunle Okesina, John Anetor, Rajiv Erasmus
African Journal of Laboratory Medicine  vol: 14  issue: 1  year: 2025  
doi: 10.4102/ajlm.v14i1.2973

2. A Colorimetric Multimetabolite Assay for Quantitative Measurement of Keto Acids in Urine for At‐Home Monitoring of Metabolic Disorders
Dipanjan Bhattacharyya, Abby Kropielnicki, Brian L. Lee, Yeganeh Khaniani, Marcia A. LeVatte, David S. Wishart, Larisa Lvova
Journal of Analytical Methods in Chemistry  vol: 2026  issue: 1  year: 2026  
doi: 10.1155/jamc/4116313

3. Epidemiological burden of inborn errors of metabolism in low- and middle-income countries: a systematic review protocol
Kavita Kachroo, Annie NithiyaVathani Johnson, S.A.K. Moinudeen, Jitendra Sharma, Cheryl Holly
JBI Evidence Synthesis  vol: 23  issue: 1  first page: 143  year: 2025  
doi: 10.11124/JBIES-23-00540

4. Lactate and pyruvate as inborn errors of metabolism screening markers and their analytical challenges—a review
Shambhavi Shetye, Ajeetkumar Patil, Varashree B. Suryakanth, Ramesh Y. Bhat, Saritha U. Kamath
Discover Applied Sciences  vol: 7  issue: 6  year: 2025  
doi: 10.1007/s42452-025-07173-0

5. Integrated Newborn Screening in Nigeria: The Way Forward, A Workshop Report
Olumuyiwa S. Folayan, Bose E. Orimadegun, Adejumoke I. Ayede, Baba P. Inusa, Marika K. Kase, John I. Anetor
International Journal of Neonatal Screening  vol: 12  issue: 1  first page: 5  year: 2026  
doi: 10.3390/ijns12010005

6. Application of targeted high-throughput sequencing as a diagnostic tool for neonatal genetic metabolic diseases following tandem mass spectrometry screening
Guihua Lai, Qiying Gu, Zhiyong Lai, Haijun Chen, Xiangwen Tu, Junkun Chen, Jungao Huang
Frontiers in Public Health  vol: 12  year: 2024  
doi: 10.3389/fpubh.2024.1461141

7. Diagnostic delay in monogenic disease: A scoping review
Rory J. Tinker, Miles Fisher, Alex F. Gimeno, Kayce Gill, Camille Ivey, Josh F. Peterson, Lisa Bastarache
Genetics in Medicine  vol: 26  issue: 4  first page: 101074  year: 2024  
doi: 10.1016/j.gim.2024.101074